Search

Author/Creator Vuylsteke, Ronald JCLM

1. Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials. (4th November 2015)

Authors:
de Gruijl, Tanja D; Koster, Bas D; van den Hout, Mari FCM; Sluijter, Berbel JR; Molenkamp, Barbara G; Vuylsteke, Ronald JCLM; van Leeuwen, Paul AM; Scheper, Rik J; van den Tol, Petrousjka; van den Eertwegh, Alfons
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Counteracting breast-cancer induced immune suppression by reactivating lymph node-resident conventional dendritic cells (LNR-cDC). (4th November 2015)

Authors:
van de Ven, Rieneke; van Pul, Kim; Aliabadi, Shaghayegh; van den Tol, Petrousjka; te Velde, Lisette A; Rutgers, Emiel JTh; Vuylsteke, Ronald JCLM; Stockmann, Hein BAC; Dubay, Christopher; Harrington, Chris; Fox, Bernard A; de Gruijl, Tanja D
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search